Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
BMEZ Quote, Financials, Valuation and Earnings
Last price:
$14.03
Seasonality move
:
-2.75%
Day range:
$13.98 - $14.09
52-week range:
$12.58 - $16.75
Dividend yield:
11.17%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
307K
Avg. volume:
270.6K
1-year change:
-11.81%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.04 | -- | -- | -- | $0.17 | 11.17% | -- |
|
BME
Blackrock Health Sciences Trust
|
$35.88 | -- | -- | -- | $0.26 | 6.52% | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
$23.90 | -- | -- | -- | $0.11 | 0.47% | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
$9.42 | -- | -- | -- | $0.17 | 6.58% | -- |
|
HQH
abrdn Healthcare Investors
|
$15.77 | -- | -- | -- | $0.54 | 7.04% | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
$17.64 | -- | -- | -- | $0.18 | 7.14% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.021 | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | 0.612 | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | 0.939 | -- | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | 0.575 | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | 0.967 | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | 0.682 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
BlackRock Health Sciences Trust II vs. Competitors
-
Which has Higher Returns BMEZ or BME?
Blackrock Health Sciences Trust has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat Blackrock Health Sciences Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- BMEBlackrock Health Sciences Trust-- -- -- -
What do Analysts Say About BMEZ or BME?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand Blackrock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than Blackrock Health Sciences Trust, analysts believe BlackRock Health Sciences Trust II is more attractive than Blackrock Health Sciences Trust.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 BMEBlackrock Health Sciences Trust0 0 0 -
Is BMEZ or BME More Risky?
BlackRock Health Sciences Trust II has a beta of 1.069, which suggesting that the stock is 6.85% more volatile than S&P 500. In comparison Blackrock Health Sciences Trust has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.401%.
-
Which is a Better Dividend Stock BMEZ or BME?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.17 per share corresponding to a yield of 11.17%. Blackrock Health Sciences Trust offers a yield of 6.52% to investors and pays a quarterly dividend of $0.26 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. Blackrock Health Sciences Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or BME?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than Blackrock Health Sciences Trust quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than Blackrock Health Sciences Trust's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while Blackrock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for Blackrock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- BMEBlackrock Health Sciences Trust-- -- -- --
-
Which has Higher Returns BMEZ or FMED?
Fidelity Disruptive Medicine ETF has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat Fidelity Disruptive Medicine ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- -
What do Analysts Say About BMEZ or FMED?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity Disruptive Medicine ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than Fidelity Disruptive Medicine ETF, analysts believe BlackRock Health Sciences Trust II is more attractive than Fidelity Disruptive Medicine ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 FMEDFidelity Disruptive Medicine ETF0 0 0 -
Is BMEZ or FMED More Risky?
BlackRock Health Sciences Trust II has a beta of 1.069, which suggesting that the stock is 6.85% more volatile than S&P 500. In comparison Fidelity Disruptive Medicine ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BMEZ or FMED?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.17 per share corresponding to a yield of 11.17%. Fidelity Disruptive Medicine ETF offers a yield of 0.47% to investors and pays a quarterly dividend of $0.11 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. Fidelity Disruptive Medicine ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or FMED?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than Fidelity Disruptive Medicine ETF quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than Fidelity Disruptive Medicine ETF's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while Fidelity Disruptive Medicine ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for Fidelity Disruptive Medicine ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- --
-
Which has Higher Returns BMEZ or GRX?
Gabelli Healthcare & WellnessRx Trust has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat Gabelli Healthcare & WellnessRx Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- GRXGabelli Healthcare & WellnessRx Trust-- -- -- -
What do Analysts Say About BMEZ or GRX?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand Gabelli Healthcare & WellnessRx Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than Gabelli Healthcare & WellnessRx Trust, analysts believe BlackRock Health Sciences Trust II is more attractive than Gabelli Healthcare & WellnessRx Trust.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 GRXGabelli Healthcare & WellnessRx Trust0 0 0 -
Is BMEZ or GRX More Risky?
BlackRock Health Sciences Trust II has a beta of 1.069, which suggesting that the stock is 6.85% more volatile than S&P 500. In comparison Gabelli Healthcare & WellnessRx Trust has a beta of 0.995, suggesting its less volatile than the S&P 500 by 0.513%.
-
Which is a Better Dividend Stock BMEZ or GRX?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.17 per share corresponding to a yield of 11.17%. Gabelli Healthcare & WellnessRx Trust offers a yield of 6.58% to investors and pays a quarterly dividend of $0.17 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. Gabelli Healthcare & WellnessRx Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or GRX?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than Gabelli Healthcare & WellnessRx Trust quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than Gabelli Healthcare & WellnessRx Trust's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while Gabelli Healthcare & WellnessRx Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for Gabelli Healthcare & WellnessRx Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- GRXGabelli Healthcare & WellnessRx Trust-- -- -- --
-
Which has Higher Returns BMEZ or HQH?
abrdn Healthcare Investors has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat abrdn Healthcare Investors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- HQHabrdn Healthcare Investors-- -- -- -
What do Analysts Say About BMEZ or HQH?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Investors has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than abrdn Healthcare Investors, analysts believe BlackRock Health Sciences Trust II is more attractive than abrdn Healthcare Investors.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 HQHabrdn Healthcare Investors0 0 0 -
Is BMEZ or HQH More Risky?
BlackRock Health Sciences Trust II has a beta of 1.069, which suggesting that the stock is 6.85% more volatile than S&P 500. In comparison abrdn Healthcare Investors has a beta of 0.806, suggesting its less volatile than the S&P 500 by 19.424%.
-
Which is a Better Dividend Stock BMEZ or HQH?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.17 per share corresponding to a yield of 11.17%. abrdn Healthcare Investors offers a yield of 7.04% to investors and pays a quarterly dividend of $0.54 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. abrdn Healthcare Investors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or HQH?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than abrdn Healthcare Investors quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than abrdn Healthcare Investors's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while abrdn Healthcare Investors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for abrdn Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- HQHabrdn Healthcare Investors-- -- -- --
-
Which has Higher Returns BMEZ or THQ?
abrdn Healthcare Opportunities Fund has a net margin of -- compared to BlackRock Health Sciences Trust II's net margin of --. BlackRock Health Sciences Trust II's return on equity of -- beat abrdn Healthcare Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEZBlackRock Health Sciences Trust II-- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- -
What do Analysts Say About BMEZ or THQ?
BlackRock Health Sciences Trust II has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Health Sciences Trust II has higher upside potential than abrdn Healthcare Opportunities Fund, analysts believe BlackRock Health Sciences Trust II is more attractive than abrdn Healthcare Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEZBlackRock Health Sciences Trust II0 0 0 THQabrdn Healthcare Opportunities Fund0 0 0 -
Is BMEZ or THQ More Risky?
BlackRock Health Sciences Trust II has a beta of 1.069, which suggesting that the stock is 6.85% more volatile than S&P 500. In comparison abrdn Healthcare Opportunities Fund has a beta of 0.909, suggesting its less volatile than the S&P 500 by 9.122%.
-
Which is a Better Dividend Stock BMEZ or THQ?
BlackRock Health Sciences Trust II has a quarterly dividend of $0.17 per share corresponding to a yield of 11.17%. abrdn Healthcare Opportunities Fund offers a yield of 7.14% to investors and pays a quarterly dividend of $0.18 per share. BlackRock Health Sciences Trust II pays -- of its earnings as a dividend. abrdn Healthcare Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMEZ or THQ?
BlackRock Health Sciences Trust II quarterly revenues are --, which are smaller than abrdn Healthcare Opportunities Fund quarterly revenues of --. BlackRock Health Sciences Trust II's net income of -- is lower than abrdn Healthcare Opportunities Fund's net income of --. Notably, BlackRock Health Sciences Trust II's price-to-earnings ratio is -- while abrdn Healthcare Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Health Sciences Trust II is -- versus -- for abrdn Healthcare Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEZBlackRock Health Sciences Trust II-- -- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
